Myeloablative Busulfan/Melphalan (BUMEL) Consolidation Following Induction Chemotherapy for Patients with High-Risk Neuroblastoma. A Children's Oncology Group (COG) Study

Granger M.

首页> 外文期刊>Pediatric blood & cancer >Myeloablative Busulfan/Melphalan (BUMEL) Consolidation Following Induction Chemotherapy for Patients with High-Risk Neuroblastoma. A Children's Oncology Group (COG) Study

【24h】

Myeloablative Busulfan/Melphalan (BUMEL) Consolidation Following Induction Chemotherapy for Patients with High-Risk Neuroblastoma. A Children's Oncology Group (COG) Study

机译：高风险神经母细胞瘤患者诱导化疗后清髓性白消安/美法仑（BUMEL）合并。儿童肿瘤学小组（COG）的研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric blood & cancer》 |2016年第3期|共1页
作者
Granger M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献

1. Myeloablative Busulfan/Melphalan (BUMEL) Consolidation Following Induction Chemotherapy for Patients with High-Risk Neuroblastoma. A Children's Oncology Group (COG) Study [J] . Granger M. Pediatric blood & cancer . 2016,第Suppla3期

机译：高风险神经母细胞瘤患者诱导化疗后清髓性白消安/美法仑（BUMEL）合并。儿童肿瘤学小组（COG）的研究
2. Late Effects in Pediatric High-risk Neuroblastoma Survivors After Intensive Induction Chemotherapy Followed by Myeloablative Consolidation Chemotherapy and Triple Autologous Stem Cell Transplants [J] . Armstrong Amy E., Danner-Koptik Karina, Golden Shannon, Journal of pediatric hematology/oncology: Official journal of the American Society of Pediatric Hematology/Oncology . 2018,第1期

机译：在密集的诱导化疗后儿科高危神经母细胞瘤幸存者的后期效应随后是髓鞘化化疗和三重自体干细胞移植剂
3. Busulfan plus melphalan versus melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma [J] . Songyi Park, Dong-Yeop Shin, Junshik Hong, Therapeutic advances in hematology. . 2021,第a期

机译：Busulfan Plus Melphalan与Melphalan独自调节方案基于Bortezomib基于Triplet诱导化疗的新诊断患者的多重骨髓瘤
4. A Phase II Feasibility Study of Oral Etoposide Given Concurrently with Radiotherapy Followed by Dose Intensive Adjuvant Chemotherapy for Children with Newly Diagnosed High-Risk Medulloblastoma; COG Protocol POG 9631 A Report from the Children’s Oncology Group [O] . Adam J. Esbenshade, Mehmet Kocak, Linda Hershon, -1

机译：口服依托泊苷与放疗同时进行剂量强化辅助化学疗法治疗新诊断的高危髓母细胞瘤儿童的II期可行性研究； COG协议POG 9631儿童肿瘤学小组的报告
5. Busulfan plus melphalan versus melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma [O] . Songyi Park, Dong-Yeop Shin, Junshik Hong, 2021

机译：Busulfan Plus Melphalan与Melphalan独自调理方案，基于Bortezomib的三联诱导化疗，用于新诊断的多发性骨髓瘤患者

Myeloablative Busulfan/Melphalan (BUMEL) Consolidation Following Induction Chemotherapy for Patients with High-Risk Neuroblastoma. A Children's Oncology Group (COG) Study

著录项

相似文献

相关主题

期刊订阅